Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (527) Arrow Down
Filter Results: (527) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (527)
    • People  (4)
    • News  (180)
    • Research  (239)
    • Multimedia  (2)
  • Faculty Publications  (136)

Show Results For

  • All HBS Web  (527)
    • People  (4)
    • News  (180)
    • Research  (239)
    • Multimedia  (2)
  • Faculty Publications  (136)
← Page 11 of 527 Results →
  • 22 May 2020
  • In Practice

Post-COVID Health Care: More Screens, Less Red Tape?

The coronavirus crisis forced health care providers to mobilize in ways few could have predicted six months ago, revealing not only the system’s weaknesses but its profound ingenuity. Within weeks, providers... View Details
Keywords: by Danielle Kost
  • January 2023
  • Case

Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery

By: Regina Herzlinger and Brian Walker
What should a successful executive (HBS Baker Scholar) assess as her next move as the CEO of a firm with a promising and yet uncertain new drug? Amy Burroughs’ mandate to successfully commercialize Cleave Therapeutics’ drug for a cancer with no current successful... View Details
Keywords: Product Development; Leadership; Health Testing and Trials; Research and Development; Risk and Uncertainty; Financial Condition; Partners and Partnerships; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Herzlinger, Regina, and Brian Walker. "Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery." Harvard Business School Case 323-045, January 2023.
  • May 2023 (Revised June 2023)
  • Case

Novartis (A): Reimagining Medicine

By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
Keywords: Health Care and Treatment; Business Model; Leadership; Pharmaceutical Industry; Switzerland
Citation
Educators
Related
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (A): Reimagining Medicine." Harvard Business School Case 723-443, May 2023. (Revised June 2023.)
  • May 2023 (Revised June 2023)
  • Supplement

Novartis (C): Reimagining Medicine

By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
Keywords: Health Testing and Trials; Health Care and Treatment; Business Model; Problems and Challenges; Pharmaceutical Industry; Switzerland
Citation
Related
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (C): Reimagining Medicine." Harvard Business School Supplement 723-445, May 2023. (Revised June 2023.)
  • May 2023 (Revised June 2023)
  • Supplement

Novartis (B): Reimagining Medicine

By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
Keywords: Health Care and Treatment; Business Model; Production; Business Strategy; Pharmaceutical Industry
Citation
Related
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (B): Reimagining Medicine." Harvard Business School Supplement 723-444, May 2023. (Revised June 2023.)
  • 2024
  • Working Paper

Gastrointestinal Endoscopy--Without Cutting In: Case Histories of Transformational Advances

By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
This case history describes how endoscopy transformed the diagnosis of ulcers, cancerous polyps, and other alimentary canal diseases and enabled “minimally invasive” surgeries to treat such diseases. Specifically, we chronicle how: 1) flexible glass fiber endoscopes... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Citation
SSRN
Read Now
Related
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "Gastrointestinal Endoscopy--Without Cutting In: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-005, July 2019. (Revised May 2024.)
  • 17 Dec 2007
  • Research & Ideas

The Rise of Medical Tourism

Patients with resources can easily go where care is provided. "Historically doctors moved from Africa and India to London and New York to provide care. Now we are basically flipping it around and... View Details
Keywords: by Martha Lagace; Health; Medical Devices & Supplies
  • 12 Mar 2020
  • Video

Ian Fuhr

Ian Fuhr, founder of Sorbet, the largest chain of beauty salons in South Africa, describes how he built the Sorbet brand through offering unconditional refunds and careful training of staff in the company’s... View Details
  • 05 Jun 2012
  • First Look

First Look: June 5

system in particular countries are instructive. It also contains exhibits that display comparative performance of the system in terms of cost and quality. It raises the question of how health View Details
Keywords: Sean Silverthorne
  • March 2014
  • Teaching Note

Oral Rehydration Therapy

By: Nava Ashraf and Natalie Kindred
This Teaching Note accompanies the case "Oral Rehydration Therapy" (911-035). The case highlights the puzzlingly high rate of diarrhea-related child mortality in developing countries despite the existence of a simple, effective treatment: oral rehydration therapy... View Details
Keywords: Health Care and Treatment; Innovation Strategy; Problems and Challenges; Developing Countries and Economies; Technological Innovation; Distribution Channels; Emerging Markets; Consumer Behavior; Performance Consistency; Performance Evaluation; Health Industry; Africa; Asia
Citation
Purchase
Related
Ashraf, Nava, and Natalie Kindred. "Oral Rehydration Therapy." Harvard Business School Teaching Note 914-038, March 2014.
  • December 2010
  • Case

Oral Rehydration Therapy

By: Nava Ashraf and Claire Qureshi
This case highlights the puzzlingly high rate of diarrhea-related child mortality in developing countries despite the existence of a simple, effective treatment: oral rehydration therapy (ORT). ORT treated extreme dehydration caused by diarrhea, which was a leading... View Details
Keywords: Health Care and Treatment; Innovation Strategy; Problems and Challenges; Developing Countries and Economies; Technological Innovation; Distribution Channels; Emerging Markets; Consumer Behavior; Performance Consistency; Performance Evaluation; Health Industry; Africa; Asia
Citation
Educators
Purchase
Related
Ashraf, Nava, and Claire Qureshi. "Oral Rehydration Therapy." Harvard Business School Case 911-035, December 2010. (Request a courtesy copy.)
  • 25 Apr 2000
  • Research & Ideas

Adjusting the Fit for Government

The role of government in Africa must be to establish an "investor friendly" environment, according to Obiageli Ezekwesili, a panelist at the Africa Business... View Details
Keywords: by Martha Lagace
  • August 2020
  • Case

Sangu Delle

By: Leslie Perlow and Matthew Preble
By 2020, Sangu Delle (MBA 2016) has already made significant progress towards his life-long goal of solving Africa’s myriad and diverse challenges. At 33 years old, he is the founder and chairman of the for-profit Golden Palm Investments Corporation, CEO of Africa... View Details
Keywords: Impact; Impact Investing; Mental Health; Social Capitalism; Entrepreneurship; Investment; Health Care and Treatment; Personal Development and Career; Health Industry; Africa
Citation
Educators
Purchase
Related
Perlow, Leslie, and Matthew Preble. "Sangu Delle." Harvard Business School Case 421-031, August 2020.
  • Research Summary

Health-care Applications

Active postmarketing drug surveillance.  There is substantial interest within the U.S. health community and among health policymakers in developing a surveillance system that scans public health databases in order to proactively detect potential drug safety... View Details

  • 27 Aug 2013
  • First Look

First Look: August 27

Factory Models for Cancer Care This case compares and contrasts four different models for delivering cancer care View Details
Keywords: Sean Silverthorne
  • August 2023
  • Case

Constellation Pharmaceuticals: Corporate Development at a Novel Therapeutic Company

By: Satish Tadikonda and Brad Prosek
Constellation Pharmaceuticals was a company focused on epigenetic therapies for cancer patients. Despite a promising start and an early deal with a leading biopharma company, the company weathered twin setbacks in the end of a major research collaboration and the... View Details
Keywords: Mergers and Acquisitions; Health Care and Treatment; Organizational Change and Adaptation; Research and Development; Business Strategy; Partners and Partnerships; Goals and Objectives; Pharmaceutical Industry; United States
Citation
Educators
Purchase
Related
Tadikonda, Satish, and Brad Prosek. "Constellation Pharmaceuticals: Corporate Development at a Novel Therapeutic Company." Harvard Business School Case 824-032, August 2023.
  • September 2010 (Revised July 2021)
  • Case

Gone Rural

By: Andre F. Perold
Gone Rural employs 750 women in rural communities across Swaziland to produce handwoven baskets and other hand-crafted items. The women are mostly grandmothers caring for children orphaned as a result of the country's high AIDS-related death rate. The company has a... View Details
Keywords: Social Enterprise; Corporate Social Responsibility and Impact; Growth and Development; Buildings and Facilities; Business Growth and Maturation; Corporate Finance; Business and Shareholder Relations; Swaziland
Citation
Educators
Purchase
Related
Perold, Andre F. "Gone Rural." Harvard Business School Case 211-016, September 2010. (Revised July 2021.)
  • Web

Employment Data

3% Entertainment / Media 3% Health Care 6% Investment Banking 5% Investment Management / Hedge Fund 6% Manufacturing 5% Nonprofit / Government 5% Other Financial Services 4% Private Equity 19% Retail 2% Services 3% Technology 16% Venture... View Details
  • 2022
  • Article

Improving Efficiency and Reducing Costs of MRI-Guided Prostate Brachytherapy Using Time-Driven Activity-Based Costing

By: Nikhil G. Thaker, Rajat J. Kudchadker, James R. Incalcaterra, Tharakeswara K. Bathala, Robert S. Kaplan, Ankit Agarwal, Deborah A. Kuban, Benjamin D. Frank, Prajnan Das, Thomas W. Feeley and Steven J. Frank
Integrated quality improvement (QI) and cost reduction strategies can help increase value in cancer care. We applied standard QI and TDABC methods to improve workflow efficiency and reduce costs for MRI-guided prostate brachytherapy. We constructed process maps,... View Details
Keywords: Brachytherapy; Quality Improvement; Prostate; Time-Driven Activity-Based Costing; Cost Accounting; Health Care and Treatment; Performance Efficiency; Health Industry
Citation
Read Now
Related
Thaker, Nikhil G., Rajat J. Kudchadker, James R. Incalcaterra, Tharakeswara K. Bathala, Robert S. Kaplan, Ankit Agarwal, Deborah A. Kuban, Benjamin D. Frank, Prajnan Das, Thomas W. Feeley, and Steven J. Frank. "Improving Efficiency and Reducing Costs of MRI-Guided Prostate Brachytherapy Using Time-Driven Activity-Based Costing." Brachytherapy 21, no. 1 (2022): 49–54.
  • March 2008 (Revised June 2008)
  • Case

The Broad Institute: Applying the Power of Genomics to Medicine

By: Vicki L. Sato and Rachel Gordon
In June 2003, Harvard University and MIT announced an unprecedented partnership to create a biomedical institute, The Broad Institute. The culture of the Broad centered on science, and those involved considered it to be at the edge of the scientific frontier. In just... View Details
Keywords: Education; Health Care and Treatment; Innovation Leadership; Growth and Development Strategy; Organizational Culture; Partners and Partnerships; Research and Development; Genetics
Citation
Educators
Purchase
Related
Sato, Vicki L., and Rachel Gordon. "The Broad Institute: Applying the Power of Genomics to Medicine." Harvard Business School Case 608-114, March 2008. (Revised June 2008.)
  • ←
  • 11
  • 12
  • …
  • 26
  • 27
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.